S 301

New Jersey Senate bill in Session 2026-2027.

Status: in_committee. Latest action: March 16, 2026.

7 Hydroxymitragynine-classifies as Schedule I drug.

Bill ID NJ-2026-2027-S-301
Session 2026-2027
Status in_committee
Committee Budget and Appropriations
Senate in_committee 2026-03-16
Summary

Classifies 7 Hydroxymitragynine as Schedule I drug.

Sponsor
Corrado, Kristin M.
Official Source Back to Bills
Actions Timeline
Date Event Detail
2026-01-13 Introduced Bill introduced
2026-03-16 Status in_committee
2026-03-16 Latest Action REF SBA
More Bills From This Sponsor
S 4331
Foreclosure Mediation Asst. Prog.-auth HMFA to make cert reimbursements
unknown • Senate
S 3233
Delta Sigma Theta Sorority, Inc. license plates-authorize creation
unknown • Senate
S 388
Multiple dwellings-prov priority status to cert residents moving to lower floors
in_committee • Senate
S 1759
Property tax credit option-increase for certain individuals
in_committee • Senate
A 1738
Delta Sigma Theta Sorority, Inc. license plates-authorize creation
unknown • General Assembly
S 1526
Senior citizen or veteran identity theft-increase penalties
in_committee • Senate